Calculation
Total asset turnover | = | Product sales1 | ÷ | Total assets1 | |
---|---|---|---|---|---|
Dec 31, 2023 | 0.36 | = | 6,671) | ÷ | 18,426) |
Dec 31, 2022 | 0.71 | = | 18,435) | ÷ | 25,858) |
Dec 31, 2021 | 0.72 | = | 17,675) | ÷ | 24,669) |
Dec 31, 2020 | 0.03 | = | 200) | ÷ | 7,337) |
Dec 31, 2019 | 0.00 | = | —) | ÷ | 1,589) |
Dec 31, 2018 | 0.00 | = | —) | ÷ | 1,962) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 US$ in millions
Comparison to Competitors
Moderna Inc. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2023 | 0.36 | 0.40 | 0.28 | 0.47 | 0.28 | 0.53 | 0.43 | 0.51 | 0.56 | 0.26 | 0.40 | 0.43 |
Dec 31, 2022 | 0.71 | 0.42 | 0.38 | 0.48 | 0.37 | 0.58 | 0.43 | 0.51 | 0.54 | 0.51 | 0.42 | 0.46 |
Dec 31, 2021 | 0.72 | 0.38 | 0.40 | 0.42 | 0.35 | 0.58 | 0.40 | 0.52 | 0.46 | 0.45 | 0.63 | 0.41 |
Dec 31, 2020 | 0.03 | 0.30 | 0.39 | 0.36 | 0.29 | 0.53 | 0.36 | 0.47 | 0.52 | 0.27 | 0.50 | 0.47 |
Dec 31, 2019 | 0.00 | 0.37 | 0.37 | 0.20 | 0.29 | 0.57 | 0.36 | 0.52 | 0.55 | 0.31 | 0.53 | 0.44 |
Dec 31, 2018 | 0.00 | 0.55 | 0.34 | 0.64 | 0.42 | 0.56 | 0.34 | 0.53 | 0.51 | 0.34 | 0.57 | 0.43 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)
Moderna Inc., total asset turnover, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)
Moderna Inc. | Pharmaceuticals, Biotechnology & Life Sciences | |
---|---|---|
Dec 31, 2023 | 0.36 | 0.40 |
Dec 31, 2022 | 0.71 | 0.48 |
Dec 31, 2021 | 0.72 | 0.45 |
Dec 31, 2020 | 0.03 | 0.38 |
Dec 31, 2019 | 0.00 | 0.39 |
Dec 31, 2018 | 0.00 | 0.45 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
Comparison to Industry (Health Care)
Moderna Inc. | Health Care | |
---|---|---|
Dec 31, 2023 | 0.36 | 0.80 |
Dec 31, 2022 | 0.71 | 0.81 |
Dec 31, 2021 | 0.72 | 0.76 |
Dec 31, 2020 | 0.03 | 0.70 |
Dec 31, 2019 | 0.00 | 0.71 |
Dec 31, 2018 | 0.00 | 0.67 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).